Lex H T Van der Ploeg Selected Research

Lex H T Van der Ploeg Research Topics

Disease

13	Body Weight (Weight, Body) 01/2018 - 04/2002
9	Obesity 01/2018 - 04/2002
2	Weight Gain 08/2021 - 06/2007
2	Inflammation (Inflammations) 08/2021 - 05/2004
2	Weight Loss (Weight Reduction) 10/2017 - 06/2007
1	Edema (Dropsy) 08/2021
1	Fibrosis (Cirrhosis) 08/2021
1	Non-alcoholic Fatty Liver Disease 08/2021
1	Morbid Obesity 01/2018
1	Neoplasms (Cancer) 03/2015
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2009
1	Insulin Resistance 07/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2006
1	Tics (Tic) 10/2005
1	Cachexia 04/2005
1	Alzheimer Disease (Alzheimer's Disease) 10/2004
1	Amyloidosis 10/2004
1	Heart Failure 05/2004
1	Erectile Dysfunction 05/2004
1	Hyperphagia (Overeating) 05/2003
1	Hyperinsulinism (Hyperinsulinemia) 05/2003
1	Hypercholesterolemia 05/2003
1	Ganglion Cysts (Ganglion) 08/2002
1	Starvation 07/2002

Drug/Important Bio-Agent (IBA)

5	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2018 - 01/2006
3	Peptides (Polypeptides)IBA 10/2017 - 08/2002
3	setmelanotideIBA 10/2017 - 03/2015
3	Neuropeptide YIBA 05/2006 - 07/2002
3	MelanocortinsIBA 10/2005 - 04/2002
2	CholesterolIBA 08/2021 - 03/2015
2	Pharmaceutical PreparationsIBA 08/2021 - 01/2006
2	DeuteriumIBA 08/2021 - 03/2015
2	Leptin ReceptorsIBA 01/2018 - 05/2006
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018 - 10/2017
2	neuropeptide Y5 receptorIBA 05/2006 - 05/2003
2	NeuropeptidesIBA 01/2006 - 07/2002
1	Pioglitazone (Actos)FDA Link 08/2021
1	Nonesterified Fatty Acids (NEFA)IBA 08/2021
1	Glucose (Dextrose)FDA LinkGeneric 08/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2021
1	Triglycerides (Triacylglycerol)IBA 08/2021
1	Monocarboxylic Acid TransportersIBA 08/2021
1	PPAR gammaIBA 08/2021
1	Proprotein Convertase 1IBA 01/2018
1	HydrogenIBA 03/2015
1	Thalidomide (Thalomid)FDA Link 03/2015
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 03/2015
1	Liraglutide FDA Link 03/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 03/2015
1	Notch ReceptorsIBA 04/2009
1	Gamma Secretase Inhibitors and ModulatorsIBA 04/2009
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2009
1	Spironolactone (Aldactone)FDA LinkGeneric 07/2008
1	sibutramine (Meridia)FDA Link 07/2008
1	Insulin (Novolin)FDA Link 07/2008
1	N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA 06/2007
1	melanin-concentrating hormone receptorIBA 04/2005
1	AmidesIBA 03/2005
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 03/2005
1	Amyloid beta-PeptidesIBA 10/2004
1	Proteins (Proteins, Gene)FDA Link 10/2004
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2004
1	Cyclic NucleotidesIBA 05/2004
1	EnzymesIBA 05/2004
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2004
1	diethylstilbestrol monophosphate (PDES)IBA 05/2004
1	LeptinIBA 07/2002
1	Agouti-Related ProteinIBA 07/2002

Therapy/Procedure

3	Therapeutics 03/2015 - 01/2006
1	Glycemic Control 03/2015
1	Lasers (Laser) 10/2004
1	Oral Administration 05/2003
1	Intraventricular Infusions 05/2003